Prostate and urologic cancer program

描述：（申请人描述）UPCI的前列腺和泌尿系统癌症项目（PUCP）专注于前列腺和其他泌尿生殖系统（GU）癌症的基础和临床研究。该项目的目标是：(1)提高对前列腺癌和其他GU癌生物学的认识；(2)开发新的肿瘤诊断和治疗方法；(3)开发适用于预防前列腺癌或其他GU癌的新概念。这些目标通过基础科学调查、转化研究和临床试验来实现。该项目的领导由Robert H. Getzenberg博士，病理学、外科、医学和药理学助理教授兼研究主任，PUCP和Donald L. Trump博士，医学和外科教授，血液学/肿瘤学主任和UPCI临床研究副主任。PUCP是一个非常互动的项目，包括泌尿外科、血液学/肿瘤学、内分泌学、病理学和其他基础科学和临床科室的成员，他们都积极参与该项目。该计划产生的许多赠款和论文是PUCP成员之间的合作努力。

Description: (Applicant's Description) The Prostate and Urologic Cancer Program (PUCP) of the UPCI focuses on the basic and clinical study of prostate and other genitourinary (GU) cancers. The Program's goals are (1) to develop improved understanding of the biology of prostate and other GU cancers; (2) to develop new diagnostic and therapeutic approaches to these tumors; and (3) to develop new concepts applicable to the prevention of prostate or other GU cancers. These goals are approached through basic science investigations, translational research studies, and clinical trials. The leadership of the Program consists of Dr. Robert H. Getzenberg, Assistant Professor of Pathology, Surgery, Medicine and Pharmacology and Director of Research, PUCP and Dr. Donald L. Trump, Professor of Medicine and Surgery, Chief of the Division of Hematology/Oncology and UPCI Deputy Director for Clinical Investigations. The PUCP is a very interactive program including members of Urology, Hematology/Oncology, Endocrinology, Pathology and other basic science and clinical departments, all actively participating in the Program. Many of the grants and papers resulting from the Program are cooperative efforts among PUCP members.